The U.S. Food and Drug Administration (FDA) established the Office of Tissues and Advanced Therapies (OTAT) to oversee the development and regulation of
The World Health Organization stated that as of 2020, nearly 8 million women alive were diagnosed with breast cancer in the last 5 years, making
IPSCs and organoids offer a powerful platform for modeling disease & drug discovery. These models can deliver accurate insights which cannot be provided by immortalized
Physiological relevance versus reproducibility — As scientists, we all recognize the limitations of developing assays using 2D immortalized cell lines and thus have dedicated our
Monoclonal cell lines are a powerful tool for biomedical research and drug development. The development and use of monoclonal cell lines have been accelerated due
Cell line development is a key tool and requirement in almost every experimental workflow in drug discovery and development. The ability to track and trace
By Jessica Hartman, Ph.D. Toiling in the lab With a deadline on its way To the scope I go On a Saturday I don’t see
You never forget the first time you thaw a vial of induced pluripotent stem cells. Standing in the lab, holding a precious vial of cells,
Generating edited monoclonal cell lines has become the first, and often the most important, step in therapeutic discovery pipelines. From editing to clonal expansion, cell
Single cell workflows are hot topics in scientific research today. The ability to turn a single cell into a viable monoclonal colony is essential for
Cell Microsystems develops innovative tools that allow researchers to image, identify, and isolate single cells and colonies for use in the fields of CRISPR gene editing, cancer research, stem cell biology, immunology, and neurobiology.
Cell Microsystems
801 Capitola Drive, Ste 10
Durham, NC 27713
252.285.9842